Global mRNA Drug Supply, Demand and Key Producers, 2026-2032
The global mRNA Drug market size is expected to reach $ 641 million by 2032, rising at a market growth of 4.9% CAGR during the forecast period (2026-2032).
In 2025, global mRNA therapeutics production capacity is about 2,250,000 doses, with actual production reaching approximately 1,750,000 doses. The average global market price is around US$ 320 per dose. The market gross margin mainly ranges between 55% and 75%. mRNA therapeutics are a class of biopharmaceutical products that use messenger RNA (mRNA) molecules to instruct cells to produce specific proteins for therapeutic purposes. After delivery into the body, the mRNA sequence enters cells and utilizes the cellular translation machinery to synthesize the encoded protein, which can trigger immune responses, replace missing proteins, or modulate disease-related biological pathways. Unlike traditional drugs that directly supply proteins or chemical compounds, mRNA therapeutics provide genetic instructions that enable cells to produce the therapeutic proteins themselves. These therapies are typically delivered using lipid nanoparticle (LNP) delivery systems to protect the mRNA and facilitate cellular uptake. mRNA therapeutics have been widely studied and developed for vaccines, cancer immunotherapy, protein replacement therapy, and rare disease treatment. Their advantages include rapid development cycles, flexible design, and scalable manufacturing processes.
The upstream of the mRNA therapeutics industry mainly includes nucleoside raw materials, plasmid DNA templates, enzymes used in in vitro transcription, lipid nanoparticle materials, and specialized biochemical reagents. These materials are critical for mRNA synthesis, purification, and formulation processes. The midstream involves mRNA sequence design, in vitro transcription, purification, encapsulation using lipid nanoparticles, formulation development, and large-scale biomanufacturing. Strict quality control and cold-chain logistics are essential to maintain product stability and efficacy. The downstream includes pharmaceutical companies, hospitals, vaccination programs, and clinical treatment systems. Applications span vaccines, oncology therapeutics, infectious disease prevention, and rare disease treatment. The industry also includes supporting services such as contract development and manufacturing organizations (CDMOs), clinical research services, and regulatory consulting.
The mRNA therapeutics market has experienced rapid expansion following the global success of mRNA-based vaccines. The platform’s flexibility and rapid development capability have made it one of the most promising technologies in modern biopharmaceutical innovation. One of the primary growth drivers is the expansion of mRNA technology beyond infectious disease vaccines. Pharmaceutical companies are actively developing mRNA-based cancer immunotherapies, protein replacement therapies, and treatments for rare genetic diseases. These applications significantly broaden the potential market scope of mRNA therapeutics. Another important factor is the continuous improvement of delivery technologies, particularly lipid nanoparticle (LNP) systems. Advances in delivery efficiency and safety are enabling mRNA drugs to target a wider range of tissues and diseases. In addition, increasing investments from governments, biotechnology companies, and venture capital funds are accelerating research and clinical development. As clinical pipelines continue to mature, mRNA therapeutics are expected to play an increasingly important role in the future pharmaceutical landscape.
This report studies the global mRNA Drug production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for mRNA Drug and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of mRNA Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global mRNA Drug total production and demand, 2021-2032, (K Dose)
Global mRNA Drug total production value, 2021-2032, (USD Million)
Global mRNA Drug production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Dose), (based on production site)
Global mRNA Drug consumption by region & country, CAGR, 2021-2032 & (K Dose)
U.S. VS China: mRNA Drug domestic production, consumption, key domestic manufacturers and share
Global mRNA Drug production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Dose)
Global mRNA Drug production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
Global mRNA Drug production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
This report profiles key players in the global mRNA Drug market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Moderna, Pfizer, Zydus Cadila, Fosun Pharma, CureVAC, BioNtech, AstraZeneca, Janssen, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World mRNA Drug market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Dose) and average price (US$/Dose) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global mRNA Drug Market, By Region:
1. How big is the global mRNA Drug market?
2. What is the demand of the global mRNA Drug market?
3. What is the year over year growth of the global mRNA Drug market?
4. What is the production and production value of the global mRNA Drug market?
5. Who are the key producers in the global mRNA Drug market?
6. What are the growth factors driving the market demand?
In 2025, global mRNA therapeutics production capacity is about 2,250,000 doses, with actual production reaching approximately 1,750,000 doses. The average global market price is around US$ 320 per dose. The market gross margin mainly ranges between 55% and 75%. mRNA therapeutics are a class of biopharmaceutical products that use messenger RNA (mRNA) molecules to instruct cells to produce specific proteins for therapeutic purposes. After delivery into the body, the mRNA sequence enters cells and utilizes the cellular translation machinery to synthesize the encoded protein, which can trigger immune responses, replace missing proteins, or modulate disease-related biological pathways. Unlike traditional drugs that directly supply proteins or chemical compounds, mRNA therapeutics provide genetic instructions that enable cells to produce the therapeutic proteins themselves. These therapies are typically delivered using lipid nanoparticle (LNP) delivery systems to protect the mRNA and facilitate cellular uptake. mRNA therapeutics have been widely studied and developed for vaccines, cancer immunotherapy, protein replacement therapy, and rare disease treatment. Their advantages include rapid development cycles, flexible design, and scalable manufacturing processes.
The upstream of the mRNA therapeutics industry mainly includes nucleoside raw materials, plasmid DNA templates, enzymes used in in vitro transcription, lipid nanoparticle materials, and specialized biochemical reagents. These materials are critical for mRNA synthesis, purification, and formulation processes. The midstream involves mRNA sequence design, in vitro transcription, purification, encapsulation using lipid nanoparticles, formulation development, and large-scale biomanufacturing. Strict quality control and cold-chain logistics are essential to maintain product stability and efficacy. The downstream includes pharmaceutical companies, hospitals, vaccination programs, and clinical treatment systems. Applications span vaccines, oncology therapeutics, infectious disease prevention, and rare disease treatment. The industry also includes supporting services such as contract development and manufacturing organizations (CDMOs), clinical research services, and regulatory consulting.
The mRNA therapeutics market has experienced rapid expansion following the global success of mRNA-based vaccines. The platform’s flexibility and rapid development capability have made it one of the most promising technologies in modern biopharmaceutical innovation. One of the primary growth drivers is the expansion of mRNA technology beyond infectious disease vaccines. Pharmaceutical companies are actively developing mRNA-based cancer immunotherapies, protein replacement therapies, and treatments for rare genetic diseases. These applications significantly broaden the potential market scope of mRNA therapeutics. Another important factor is the continuous improvement of delivery technologies, particularly lipid nanoparticle (LNP) systems. Advances in delivery efficiency and safety are enabling mRNA drugs to target a wider range of tissues and diseases. In addition, increasing investments from governments, biotechnology companies, and venture capital funds are accelerating research and clinical development. As clinical pipelines continue to mature, mRNA therapeutics are expected to play an increasingly important role in the future pharmaceutical landscape.
This report studies the global mRNA Drug production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for mRNA Drug and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of mRNA Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global mRNA Drug total production and demand, 2021-2032, (K Dose)
Global mRNA Drug total production value, 2021-2032, (USD Million)
Global mRNA Drug production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Dose), (based on production site)
Global mRNA Drug consumption by region & country, CAGR, 2021-2032 & (K Dose)
U.S. VS China: mRNA Drug domestic production, consumption, key domestic manufacturers and share
Global mRNA Drug production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Dose)
Global mRNA Drug production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
Global mRNA Drug production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
This report profiles key players in the global mRNA Drug market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Moderna, Pfizer, Zydus Cadila, Fosun Pharma, CureVAC, BioNtech, AstraZeneca, Janssen, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World mRNA Drug market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Dose) and average price (US$/Dose) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global mRNA Drug Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Prophylactic Vaccine (Infectious Disease)
- Therapeutic Vaccine (Cancer)
- Intramuscular (Dendritic Cell) mRNA
- Intravenous (Liver-targeted) mRNA
- Intradermal (Skin APC) mRNA
- Inhalation (Lung epithelial) mRNA
- Lab-scale (Preclinical, <1g)
- Pilot-scale (Phase I/II, 1-100g)
- Commercial-scale (Phase III/Market, >100g)
- Pharmaceutical Companies
- Medical Institutions
- Others
- Moderna
- Pfizer
- Zydus Cadila
- Fosun Pharma
- CureVAC
- BioNtech
- AstraZeneca
- Janssen
1. How big is the global mRNA Drug market?
2. What is the demand of the global mRNA Drug market?
3. What is the year over year growth of the global mRNA Drug market?
4. What is the production and production value of the global mRNA Drug market?
5. Who are the key producers in the global mRNA Drug market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 mRNA Drug Introduction
1.2 World mRNA Drug Supply & Forecast
1.2.1 World mRNA Drug Production Value (2021 & 2025 & 2032)
1.2.2 World mRNA Drug Production (2021-2032)
1.2.3 World mRNA Drug Pricing Trends (2021-2032)
1.3 World mRNA Drug Production by Region (Based on Production Site)
1.3.1 World mRNA Drug Production Value by Region (2021-2032)
1.3.2 World mRNA Drug Production by Region (2021-2032)
1.3.3 World mRNA Drug Average Price by Region (2021-2032)
1.3.4 North America mRNA Drug Production (2021-2032)
1.3.5 Europe mRNA Drug Production (2021-2032)
1.3.6 China mRNA Drug Production (2021-2032)
1.3.7 Japan mRNA Drug Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 mRNA Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 mRNA Drug Major Market Trends
2 DEMAND SUMMARY
2.1 World mRNA Drug Demand (2021-2032)
2.2 World mRNA Drug Consumption by Region
2.2.1 World mRNA Drug Consumption by Region (2021-2026)
2.2.2 World mRNA Drug Consumption Forecast by Region (2027-2032)
2.3 United States mRNA Drug Consumption (2021-2032)
2.4 China mRNA Drug Consumption (2021-2032)
2.5 Europe mRNA Drug Consumption (2021-2032)
2.6 Japan mRNA Drug Consumption (2021-2032)
2.7 South Korea mRNA Drug Consumption (2021-2032)
2.8 ASEAN mRNA Drug Consumption (2021-2032)
2.9 India mRNA Drug Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World mRNA Drug Production Value by Manufacturer (2021-2026)
3.2 World mRNA Drug Production by Manufacturer (2021-2026)
3.3 World mRNA Drug Average Price by Manufacturer (2021-2026)
3.4 mRNA Drug Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global mRNA Drug Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for mRNA Drug in 2025
3.5.3 Global Concentration Ratios (CR8) for mRNA Drug in 2025
3.6 mRNA Drug Market: Overall Company Footprint Analysis
3.6.1 mRNA Drug Market: Region Footprint
3.6.2 mRNA Drug Market: Company Product Type Footprint
3.6.3 mRNA Drug Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: mRNA Drug Production Value Comparison
4.1.1 United States VS China: mRNA Drug Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: mRNA Drug Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: mRNA Drug Production Comparison
4.2.1 United States VS China: mRNA Drug Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: mRNA Drug Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: mRNA Drug Consumption Comparison
4.3.1 United States VS China: mRNA Drug Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: mRNA Drug Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based mRNA Drug Manufacturers and Market Share, 2021-2026
4.4.1 United States Based mRNA Drug Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers mRNA Drug Production Value (2021-2026)
4.4.3 United States Based Manufacturers mRNA Drug Production (2021-2026)
4.5 China Based mRNA Drug Manufacturers and Market Share
4.5.1 China Based mRNA Drug Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers mRNA Drug Production Value (2021-2026)
4.5.3 China Based Manufacturers mRNA Drug Production (2021-2026)
4.6 Rest of World Based mRNA Drug Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based mRNA Drug Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers mRNA Drug Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers mRNA Drug Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World mRNA Drug Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Prophylactic Vaccine (Infectious Disease)
5.2.2 Therapeutic Vaccine (Cancer)
5.3 Market Segment by Type
5.3.1 World mRNA Drug Production by Type (2021-2032)
5.3.2 World mRNA Drug Production Value by Type (2021-2032)
5.3.3 World mRNA Drug Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY TARGET CELL
6.1 World mRNA Drug Market Size Overview by Target Cell: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Target Cell
6.2.1 Intramuscular (Dendritic Cell) mRNA
6.2.2 Intravenous (Liver-targeted) mRNA
6.2.3 Intradermal (Skin APC) mRNA
6.2.4 Inhalation (Lung epithelial) mRNA
6.3 Market Segment by Target Cell
6.3.1 World mRNA Drug Production by Target Cell (2021-2032)
6.3.2 World mRNA Drug Production Value by Target Cell (2021-2032)
6.3.3 World mRNA Drug Average Price by Target Cell (2021-2032)
7 MARKET ANALYSIS BY MANUFACTURING SCALE
7.1 World mRNA Drug Market Size Overview by Manufacturing Scale: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Manufacturing Scale
7.2.1 Lab-scale (Preclinical, <1g)
7.2.2 Pilot-scale (Phase I/II, 1-100g)
7.2.3 Commercial-scale (Phase III/Market, >100g)
7.3 Market Segment by Manufacturing Scale
7.3.1 World mRNA Drug Production by Manufacturing Scale (2021-2032)
7.3.2 World mRNA Drug Production Value by Manufacturing Scale (2021-2032)
7.3.3 World mRNA Drug Average Price by Manufacturing Scale (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World mRNA Drug Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Pharmaceutical Companies
8.2.2 Medical Institutions
8.2.3 Others
8.3 Market Segment by Application
8.3.1 World mRNA Drug Production by Application (2021-2032)
8.3.2 World mRNA Drug Production Value by Application (2021-2032)
8.3.3 World mRNA Drug Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Moderna
9.1.1 Moderna Details
9.1.2 Moderna Major Business
9.1.3 Moderna mRNA Drug Product and Services
9.1.4 Moderna mRNA Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Moderna Recent Developments/Updates
9.1.6 Moderna Competitive Strengths & Weaknesses
9.2 Pfizer
9.2.1 Pfizer Details
9.2.2 Pfizer Major Business
9.2.3 Pfizer mRNA Drug Product and Services
9.2.4 Pfizer mRNA Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Pfizer Recent Developments/Updates
9.2.6 Pfizer Competitive Strengths & Weaknesses
9.3 Zydus Cadila
9.3.1 Zydus Cadila Details
9.3.2 Zydus Cadila Major Business
9.3.3 Zydus Cadila mRNA Drug Product and Services
9.3.4 Zydus Cadila mRNA Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Zydus Cadila Recent Developments/Updates
9.3.6 Zydus Cadila Competitive Strengths & Weaknesses
9.4 Fosun Pharma
9.4.1 Fosun Pharma Details
9.4.2 Fosun Pharma Major Business
9.4.3 Fosun Pharma mRNA Drug Product and Services
9.4.4 Fosun Pharma mRNA Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Fosun Pharma Recent Developments/Updates
9.4.6 Fosun Pharma Competitive Strengths & Weaknesses
9.5 CureVAC
9.5.1 CureVAC Details
9.5.2 CureVAC Major Business
9.5.3 CureVAC mRNA Drug Product and Services
9.5.4 CureVAC mRNA Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 CureVAC Recent Developments/Updates
9.5.6 CureVAC Competitive Strengths & Weaknesses
9.6 BioNtech
9.6.1 BioNtech Details
9.6.2 BioNtech Major Business
9.6.3 BioNtech mRNA Drug Product and Services
9.6.4 BioNtech mRNA Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 BioNtech Recent Developments/Updates
9.6.6 BioNtech Competitive Strengths & Weaknesses
9.7 AstraZeneca
9.7.1 AstraZeneca Details
9.7.2 AstraZeneca Major Business
9.7.3 AstraZeneca mRNA Drug Product and Services
9.7.4 AstraZeneca mRNA Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 AstraZeneca Recent Developments/Updates
9.7.6 AstraZeneca Competitive Strengths & Weaknesses
9.8 Janssen
9.8.1 Janssen Details
9.8.2 Janssen Major Business
9.8.3 Janssen mRNA Drug Product and Services
9.8.4 Janssen mRNA Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 Janssen Recent Developments/Updates
9.8.6 Janssen Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 mRNA Drug Industry Chain
10.2 mRNA Drug Upstream Analysis
10.2.1 mRNA Drug Core Raw Materials
10.2.2 Main Manufacturers of mRNA Drug Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 mRNA Drug Production Mode
10.6 mRNA Drug Procurement Model
10.7 mRNA Drug Industry Sales Model and Sales Channels
10.7.1 mRNA Drug Sales Model
10.7.2 mRNA Drug Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 mRNA Drug Introduction
1.2 World mRNA Drug Supply & Forecast
1.2.1 World mRNA Drug Production Value (2021 & 2025 & 2032)
1.2.2 World mRNA Drug Production (2021-2032)
1.2.3 World mRNA Drug Pricing Trends (2021-2032)
1.3 World mRNA Drug Production by Region (Based on Production Site)
1.3.1 World mRNA Drug Production Value by Region (2021-2032)
1.3.2 World mRNA Drug Production by Region (2021-2032)
1.3.3 World mRNA Drug Average Price by Region (2021-2032)
1.3.4 North America mRNA Drug Production (2021-2032)
1.3.5 Europe mRNA Drug Production (2021-2032)
1.3.6 China mRNA Drug Production (2021-2032)
1.3.7 Japan mRNA Drug Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 mRNA Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 mRNA Drug Major Market Trends
2 DEMAND SUMMARY
2.1 World mRNA Drug Demand (2021-2032)
2.2 World mRNA Drug Consumption by Region
2.2.1 World mRNA Drug Consumption by Region (2021-2026)
2.2.2 World mRNA Drug Consumption Forecast by Region (2027-2032)
2.3 United States mRNA Drug Consumption (2021-2032)
2.4 China mRNA Drug Consumption (2021-2032)
2.5 Europe mRNA Drug Consumption (2021-2032)
2.6 Japan mRNA Drug Consumption (2021-2032)
2.7 South Korea mRNA Drug Consumption (2021-2032)
2.8 ASEAN mRNA Drug Consumption (2021-2032)
2.9 India mRNA Drug Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World mRNA Drug Production Value by Manufacturer (2021-2026)
3.2 World mRNA Drug Production by Manufacturer (2021-2026)
3.3 World mRNA Drug Average Price by Manufacturer (2021-2026)
3.4 mRNA Drug Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global mRNA Drug Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for mRNA Drug in 2025
3.5.3 Global Concentration Ratios (CR8) for mRNA Drug in 2025
3.6 mRNA Drug Market: Overall Company Footprint Analysis
3.6.1 mRNA Drug Market: Region Footprint
3.6.2 mRNA Drug Market: Company Product Type Footprint
3.6.3 mRNA Drug Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: mRNA Drug Production Value Comparison
4.1.1 United States VS China: mRNA Drug Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: mRNA Drug Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: mRNA Drug Production Comparison
4.2.1 United States VS China: mRNA Drug Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: mRNA Drug Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: mRNA Drug Consumption Comparison
4.3.1 United States VS China: mRNA Drug Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: mRNA Drug Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based mRNA Drug Manufacturers and Market Share, 2021-2026
4.4.1 United States Based mRNA Drug Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers mRNA Drug Production Value (2021-2026)
4.4.3 United States Based Manufacturers mRNA Drug Production (2021-2026)
4.5 China Based mRNA Drug Manufacturers and Market Share
4.5.1 China Based mRNA Drug Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers mRNA Drug Production Value (2021-2026)
4.5.3 China Based Manufacturers mRNA Drug Production (2021-2026)
4.6 Rest of World Based mRNA Drug Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based mRNA Drug Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers mRNA Drug Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers mRNA Drug Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World mRNA Drug Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Prophylactic Vaccine (Infectious Disease)
5.2.2 Therapeutic Vaccine (Cancer)
5.3 Market Segment by Type
5.3.1 World mRNA Drug Production by Type (2021-2032)
5.3.2 World mRNA Drug Production Value by Type (2021-2032)
5.3.3 World mRNA Drug Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY TARGET CELL
6.1 World mRNA Drug Market Size Overview by Target Cell: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Target Cell
6.2.1 Intramuscular (Dendritic Cell) mRNA
6.2.2 Intravenous (Liver-targeted) mRNA
6.2.3 Intradermal (Skin APC) mRNA
6.2.4 Inhalation (Lung epithelial) mRNA
6.3 Market Segment by Target Cell
6.3.1 World mRNA Drug Production by Target Cell (2021-2032)
6.3.2 World mRNA Drug Production Value by Target Cell (2021-2032)
6.3.3 World mRNA Drug Average Price by Target Cell (2021-2032)
7 MARKET ANALYSIS BY MANUFACTURING SCALE
7.1 World mRNA Drug Market Size Overview by Manufacturing Scale: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Manufacturing Scale
7.2.1 Lab-scale (Preclinical, <1g)
7.2.2 Pilot-scale (Phase I/II, 1-100g)
7.2.3 Commercial-scale (Phase III/Market, >100g)
7.3 Market Segment by Manufacturing Scale
7.3.1 World mRNA Drug Production by Manufacturing Scale (2021-2032)
7.3.2 World mRNA Drug Production Value by Manufacturing Scale (2021-2032)
7.3.3 World mRNA Drug Average Price by Manufacturing Scale (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World mRNA Drug Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Pharmaceutical Companies
8.2.2 Medical Institutions
8.2.3 Others
8.3 Market Segment by Application
8.3.1 World mRNA Drug Production by Application (2021-2032)
8.3.2 World mRNA Drug Production Value by Application (2021-2032)
8.3.3 World mRNA Drug Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Moderna
9.1.1 Moderna Details
9.1.2 Moderna Major Business
9.1.3 Moderna mRNA Drug Product and Services
9.1.4 Moderna mRNA Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Moderna Recent Developments/Updates
9.1.6 Moderna Competitive Strengths & Weaknesses
9.2 Pfizer
9.2.1 Pfizer Details
9.2.2 Pfizer Major Business
9.2.3 Pfizer mRNA Drug Product and Services
9.2.4 Pfizer mRNA Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Pfizer Recent Developments/Updates
9.2.6 Pfizer Competitive Strengths & Weaknesses
9.3 Zydus Cadila
9.3.1 Zydus Cadila Details
9.3.2 Zydus Cadila Major Business
9.3.3 Zydus Cadila mRNA Drug Product and Services
9.3.4 Zydus Cadila mRNA Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Zydus Cadila Recent Developments/Updates
9.3.6 Zydus Cadila Competitive Strengths & Weaknesses
9.4 Fosun Pharma
9.4.1 Fosun Pharma Details
9.4.2 Fosun Pharma Major Business
9.4.3 Fosun Pharma mRNA Drug Product and Services
9.4.4 Fosun Pharma mRNA Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Fosun Pharma Recent Developments/Updates
9.4.6 Fosun Pharma Competitive Strengths & Weaknesses
9.5 CureVAC
9.5.1 CureVAC Details
9.5.2 CureVAC Major Business
9.5.3 CureVAC mRNA Drug Product and Services
9.5.4 CureVAC mRNA Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 CureVAC Recent Developments/Updates
9.5.6 CureVAC Competitive Strengths & Weaknesses
9.6 BioNtech
9.6.1 BioNtech Details
9.6.2 BioNtech Major Business
9.6.3 BioNtech mRNA Drug Product and Services
9.6.4 BioNtech mRNA Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 BioNtech Recent Developments/Updates
9.6.6 BioNtech Competitive Strengths & Weaknesses
9.7 AstraZeneca
9.7.1 AstraZeneca Details
9.7.2 AstraZeneca Major Business
9.7.3 AstraZeneca mRNA Drug Product and Services
9.7.4 AstraZeneca mRNA Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 AstraZeneca Recent Developments/Updates
9.7.6 AstraZeneca Competitive Strengths & Weaknesses
9.8 Janssen
9.8.1 Janssen Details
9.8.2 Janssen Major Business
9.8.3 Janssen mRNA Drug Product and Services
9.8.4 Janssen mRNA Drug Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 Janssen Recent Developments/Updates
9.8.6 Janssen Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 mRNA Drug Industry Chain
10.2 mRNA Drug Upstream Analysis
10.2.1 mRNA Drug Core Raw Materials
10.2.2 Main Manufacturers of mRNA Drug Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 mRNA Drug Production Mode
10.6 mRNA Drug Procurement Model
10.7 mRNA Drug Industry Sales Model and Sales Channels
10.7.1 mRNA Drug Sales Model
10.7.2 mRNA Drug Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World mRNA Drug Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World mRNA Drug Production Value by Region (2021-2026) & (USD Million)
Table 3. World mRNA Drug Production Value by Region (2027-2032) & (USD Million)
Table 4. World mRNA Drug Production Value Market Share by Region (2021-2026)
Table 5. World mRNA Drug Production Value Market Share by Region (2027-2032)
Table 6. World mRNA Drug Production by Region (2021-2026) & (K Dose)
Table 7. World mRNA Drug Production by Region (2027-2032) & (K Dose)
Table 8. World mRNA Drug Production Market Share by Region (2021-2026)
Table 9. World mRNA Drug Production Market Share by Region (2027-2032)
Table 10. World mRNA Drug Average Price by Region (2021-2026) & (US$/Dose)
Table 11. World mRNA Drug Average Price by Region (2027-2032) & (US$/Dose)
Table 12. mRNA Drug Major Market Trends
Table 13. World mRNA Drug Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Dose)
Table 14. World mRNA Drug Consumption by Region (2021-2026) & (K Dose)
Table 15. World mRNA Drug Consumption Forecast by Region (2027-2032) & (K Dose)
Table 16. World mRNA Drug Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key mRNA Drug Producers in 2025
Table 18. World mRNA Drug Production by Manufacturer (2021-2026) & (K Dose)
Table 19. Production Market Share of Key mRNA Drug Producers in 2025
Table 20. World mRNA Drug Average Price by Manufacturer (2021-2026) & (US$/Dose)
Table 21. Global mRNA Drug Company Evaluation Quadrant
Table 22. World mRNA Drug Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and mRNA Drug Production Site of Key Manufacturer
Table 24. mRNA Drug Market: Company Product Type Footprint
Table 25. mRNA Drug Market: Company Product Application Footprint
Table 26. mRNA Drug Competitive Factors
Table 27. mRNA Drug New Entrant and Capacity Expansion Plans
Table 28. mRNA Drug Mergers & Acquisitions Activity
Table 29. United States VS China mRNA Drug Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China mRNA Drug Production Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 31. United States VS China mRNA Drug Consumption Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 32. United States Based mRNA Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers mRNA Drug Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers mRNA Drug Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers mRNA Drug Production (2021-2026) & (K Dose)
Table 36. United States Based Manufacturers mRNA Drug Production Market Share (2021-2026)
Table 37. China Based mRNA Drug Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers mRNA Drug Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers mRNA Drug Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers mRNA Drug Production, (2021-2026) & (K Dose)
Table 41. China Based Manufacturers mRNA Drug Production Market Share (2021-2026)
Table 42. Rest of World Based mRNA Drug Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers mRNA Drug Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers mRNA Drug Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers mRNA Drug Production, (2021-2026) & (K Dose)
Table 46. Rest of World Based Manufacturers mRNA Drug Production Market Share (2021-2026)
Table 47. World mRNA Drug Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World mRNA Drug Production by Type (2021-2026) & (K Dose)
Table 49. World mRNA Drug Production by Type (2027-2032) & (K Dose)
Table 50. World mRNA Drug Production Value by Type (2021-2026) & (USD Million)
Table 51. World mRNA Drug Production Value by Type (2027-2032) & (USD Million)
Table 52. World mRNA Drug Average Price by Type (2021-2026) & (US$/Dose)
Table 53. World mRNA Drug Average Price by Type (2027-2032) & (US$/Dose)
Table 54. World mRNA Drug Production Value by Target Cell, (USD Million), 2021 & 2025 & 2032
Table 55. World mRNA Drug Production by Target Cell (2021-2026) & (K Dose)
Table 56. World mRNA Drug Production by Target Cell (2027-2032) & (K Dose)
Table 57. World mRNA Drug Production Value by Target Cell (2021-2026) & (USD Million)
Table 58. World mRNA Drug Production Value by Target Cell (2027-2032) & (USD Million)
Table 59. World mRNA Drug Average Price by Target Cell (2021-2026) & (US$/Dose)
Table 60. World mRNA Drug Average Price by Target Cell (2027-2032) & (US$/Dose)
Table 61. World mRNA Drug Production Value by Manufacturing Scale, (USD Million), 2021 & 2025 & 2032
Table 62. World mRNA Drug Production by Manufacturing Scale (2021-2026) & (K Dose)
Table 63. World mRNA Drug Production by Manufacturing Scale (2027-2032) & (K Dose)
Table 64. World mRNA Drug Production Value by Manufacturing Scale (2021-2026) & (USD Million)
Table 65. World mRNA Drug Production Value by Manufacturing Scale (2027-2032) & (USD Million)
Table 66. World mRNA Drug Average Price by Manufacturing Scale (2021-2026) & (US$/Dose)
Table 67. World mRNA Drug Average Price by Manufacturing Scale (2027-2032) & (US$/Dose)
Table 68. World mRNA Drug Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World mRNA Drug Production by Application (2021-2026) & (K Dose)
Table 70. World mRNA Drug Production by Application (2027-2032) & (K Dose)
Table 71. World mRNA Drug Production Value by Application (2021-2026) & (USD Million)
Table 72. World mRNA Drug Production Value by Application (2027-2032) & (USD Million)
Table 73. World mRNA Drug Average Price by Application (2021-2026) & (US$/Dose)
Table 74. World mRNA Drug Average Price by Application (2027-2032) & (US$/Dose)
Table 75. Moderna Basic Information, Manufacturing Base and Competitors
Table 76. Moderna Major Business
Table 77. Moderna mRNA Drug Product and Services
Table 78. Moderna mRNA Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Moderna Recent Developments/Updates
Table 80. Moderna Competitive Strengths & Weaknesses
Table 81. Pfizer Basic Information, Manufacturing Base and Competitors
Table 82. Pfizer Major Business
Table 83. Pfizer mRNA Drug Product and Services
Table 84. Pfizer mRNA Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Pfizer Recent Developments/Updates
Table 86. Pfizer Competitive Strengths & Weaknesses
Table 87. Zydus Cadila Basic Information, Manufacturing Base and Competitors
Table 88. Zydus Cadila Major Business
Table 89. Zydus Cadila mRNA Drug Product and Services
Table 90. Zydus Cadila mRNA Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Zydus Cadila Recent Developments/Updates
Table 92. Zydus Cadila Competitive Strengths & Weaknesses
Table 93. Fosun Pharma Basic Information, Manufacturing Base and Competitors
Table 94. Fosun Pharma Major Business
Table 95. Fosun Pharma mRNA Drug Product and Services
Table 96. Fosun Pharma mRNA Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Fosun Pharma Recent Developments/Updates
Table 98. Fosun Pharma Competitive Strengths & Weaknesses
Table 99. CureVAC Basic Information, Manufacturing Base and Competitors
Table 100. CureVAC Major Business
Table 101. CureVAC mRNA Drug Product and Services
Table 102. CureVAC mRNA Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. CureVAC Recent Developments/Updates
Table 104. CureVAC Competitive Strengths & Weaknesses
Table 105. BioNtech Basic Information, Manufacturing Base and Competitors
Table 106. BioNtech Major Business
Table 107. BioNtech mRNA Drug Product and Services
Table 108. BioNtech mRNA Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. BioNtech Recent Developments/Updates
Table 110. BioNtech Competitive Strengths & Weaknesses
Table 111. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 112. AstraZeneca Major Business
Table 113. AstraZeneca mRNA Drug Product and Services
Table 114. AstraZeneca mRNA Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. AstraZeneca Recent Developments/Updates
Table 116. AstraZeneca Competitive Strengths & Weaknesses
Table 117. Janssen Basic Information, Manufacturing Base and Competitors
Table 118. Janssen Major Business
Table 119. Janssen mRNA Drug Product and Services
Table 120. Janssen mRNA Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Janssen Recent Developments/Updates
Table 122. Janssen Competitive Strengths & Weaknesses
Table 123. Global Key Players of mRNA Drug Upstream (Raw Materials)
Table 124. Global mRNA Drug Typical Customers
Table 125. mRNA Drug Typical Distributors
Table 1. World mRNA Drug Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World mRNA Drug Production Value by Region (2021-2026) & (USD Million)
Table 3. World mRNA Drug Production Value by Region (2027-2032) & (USD Million)
Table 4. World mRNA Drug Production Value Market Share by Region (2021-2026)
Table 5. World mRNA Drug Production Value Market Share by Region (2027-2032)
Table 6. World mRNA Drug Production by Region (2021-2026) & (K Dose)
Table 7. World mRNA Drug Production by Region (2027-2032) & (K Dose)
Table 8. World mRNA Drug Production Market Share by Region (2021-2026)
Table 9. World mRNA Drug Production Market Share by Region (2027-2032)
Table 10. World mRNA Drug Average Price by Region (2021-2026) & (US$/Dose)
Table 11. World mRNA Drug Average Price by Region (2027-2032) & (US$/Dose)
Table 12. mRNA Drug Major Market Trends
Table 13. World mRNA Drug Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Dose)
Table 14. World mRNA Drug Consumption by Region (2021-2026) & (K Dose)
Table 15. World mRNA Drug Consumption Forecast by Region (2027-2032) & (K Dose)
Table 16. World mRNA Drug Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key mRNA Drug Producers in 2025
Table 18. World mRNA Drug Production by Manufacturer (2021-2026) & (K Dose)
Table 19. Production Market Share of Key mRNA Drug Producers in 2025
Table 20. World mRNA Drug Average Price by Manufacturer (2021-2026) & (US$/Dose)
Table 21. Global mRNA Drug Company Evaluation Quadrant
Table 22. World mRNA Drug Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and mRNA Drug Production Site of Key Manufacturer
Table 24. mRNA Drug Market: Company Product Type Footprint
Table 25. mRNA Drug Market: Company Product Application Footprint
Table 26. mRNA Drug Competitive Factors
Table 27. mRNA Drug New Entrant and Capacity Expansion Plans
Table 28. mRNA Drug Mergers & Acquisitions Activity
Table 29. United States VS China mRNA Drug Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China mRNA Drug Production Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 31. United States VS China mRNA Drug Consumption Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 32. United States Based mRNA Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers mRNA Drug Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers mRNA Drug Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers mRNA Drug Production (2021-2026) & (K Dose)
Table 36. United States Based Manufacturers mRNA Drug Production Market Share (2021-2026)
Table 37. China Based mRNA Drug Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers mRNA Drug Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers mRNA Drug Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers mRNA Drug Production, (2021-2026) & (K Dose)
Table 41. China Based Manufacturers mRNA Drug Production Market Share (2021-2026)
Table 42. Rest of World Based mRNA Drug Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers mRNA Drug Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers mRNA Drug Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers mRNA Drug Production, (2021-2026) & (K Dose)
Table 46. Rest of World Based Manufacturers mRNA Drug Production Market Share (2021-2026)
Table 47. World mRNA Drug Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World mRNA Drug Production by Type (2021-2026) & (K Dose)
Table 49. World mRNA Drug Production by Type (2027-2032) & (K Dose)
Table 50. World mRNA Drug Production Value by Type (2021-2026) & (USD Million)
Table 51. World mRNA Drug Production Value by Type (2027-2032) & (USD Million)
Table 52. World mRNA Drug Average Price by Type (2021-2026) & (US$/Dose)
Table 53. World mRNA Drug Average Price by Type (2027-2032) & (US$/Dose)
Table 54. World mRNA Drug Production Value by Target Cell, (USD Million), 2021 & 2025 & 2032
Table 55. World mRNA Drug Production by Target Cell (2021-2026) & (K Dose)
Table 56. World mRNA Drug Production by Target Cell (2027-2032) & (K Dose)
Table 57. World mRNA Drug Production Value by Target Cell (2021-2026) & (USD Million)
Table 58. World mRNA Drug Production Value by Target Cell (2027-2032) & (USD Million)
Table 59. World mRNA Drug Average Price by Target Cell (2021-2026) & (US$/Dose)
Table 60. World mRNA Drug Average Price by Target Cell (2027-2032) & (US$/Dose)
Table 61. World mRNA Drug Production Value by Manufacturing Scale, (USD Million), 2021 & 2025 & 2032
Table 62. World mRNA Drug Production by Manufacturing Scale (2021-2026) & (K Dose)
Table 63. World mRNA Drug Production by Manufacturing Scale (2027-2032) & (K Dose)
Table 64. World mRNA Drug Production Value by Manufacturing Scale (2021-2026) & (USD Million)
Table 65. World mRNA Drug Production Value by Manufacturing Scale (2027-2032) & (USD Million)
Table 66. World mRNA Drug Average Price by Manufacturing Scale (2021-2026) & (US$/Dose)
Table 67. World mRNA Drug Average Price by Manufacturing Scale (2027-2032) & (US$/Dose)
Table 68. World mRNA Drug Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World mRNA Drug Production by Application (2021-2026) & (K Dose)
Table 70. World mRNA Drug Production by Application (2027-2032) & (K Dose)
Table 71. World mRNA Drug Production Value by Application (2021-2026) & (USD Million)
Table 72. World mRNA Drug Production Value by Application (2027-2032) & (USD Million)
Table 73. World mRNA Drug Average Price by Application (2021-2026) & (US$/Dose)
Table 74. World mRNA Drug Average Price by Application (2027-2032) & (US$/Dose)
Table 75. Moderna Basic Information, Manufacturing Base and Competitors
Table 76. Moderna Major Business
Table 77. Moderna mRNA Drug Product and Services
Table 78. Moderna mRNA Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Moderna Recent Developments/Updates
Table 80. Moderna Competitive Strengths & Weaknesses
Table 81. Pfizer Basic Information, Manufacturing Base and Competitors
Table 82. Pfizer Major Business
Table 83. Pfizer mRNA Drug Product and Services
Table 84. Pfizer mRNA Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Pfizer Recent Developments/Updates
Table 86. Pfizer Competitive Strengths & Weaknesses
Table 87. Zydus Cadila Basic Information, Manufacturing Base and Competitors
Table 88. Zydus Cadila Major Business
Table 89. Zydus Cadila mRNA Drug Product and Services
Table 90. Zydus Cadila mRNA Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Zydus Cadila Recent Developments/Updates
Table 92. Zydus Cadila Competitive Strengths & Weaknesses
Table 93. Fosun Pharma Basic Information, Manufacturing Base and Competitors
Table 94. Fosun Pharma Major Business
Table 95. Fosun Pharma mRNA Drug Product and Services
Table 96. Fosun Pharma mRNA Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Fosun Pharma Recent Developments/Updates
Table 98. Fosun Pharma Competitive Strengths & Weaknesses
Table 99. CureVAC Basic Information, Manufacturing Base and Competitors
Table 100. CureVAC Major Business
Table 101. CureVAC mRNA Drug Product and Services
Table 102. CureVAC mRNA Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. CureVAC Recent Developments/Updates
Table 104. CureVAC Competitive Strengths & Weaknesses
Table 105. BioNtech Basic Information, Manufacturing Base and Competitors
Table 106. BioNtech Major Business
Table 107. BioNtech mRNA Drug Product and Services
Table 108. BioNtech mRNA Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. BioNtech Recent Developments/Updates
Table 110. BioNtech Competitive Strengths & Weaknesses
Table 111. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 112. AstraZeneca Major Business
Table 113. AstraZeneca mRNA Drug Product and Services
Table 114. AstraZeneca mRNA Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. AstraZeneca Recent Developments/Updates
Table 116. AstraZeneca Competitive Strengths & Weaknesses
Table 117. Janssen Basic Information, Manufacturing Base and Competitors
Table 118. Janssen Major Business
Table 119. Janssen mRNA Drug Product and Services
Table 120. Janssen mRNA Drug Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Janssen Recent Developments/Updates
Table 122. Janssen Competitive Strengths & Weaknesses
Table 123. Global Key Players of mRNA Drug Upstream (Raw Materials)
Table 124. Global mRNA Drug Typical Customers
Table 125. mRNA Drug Typical Distributors
LIST OF FIGURES
Figure 1. mRNA Drug Picture
Figure 2. World mRNA Drug Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World mRNA Drug Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World mRNA Drug Production (2021-2032) & (K Dose)
Figure 5. World mRNA Drug Average Price (2021-2032) & (US$/Dose)
Figure 6. World mRNA Drug Production Value Market Share by Region (2021-2032)
Figure 7. World mRNA Drug Production Market Share by Region (2021-2032)
Figure 8. North America mRNA Drug Production (2021-2032) & (K Dose)
Figure 9. Europe mRNA Drug Production (2021-2032) & (K Dose)
Figure 10. China mRNA Drug Production (2021-2032) & (K Dose)
Figure 11. Japan mRNA Drug Production (2021-2032) & (K Dose)
Figure 12. mRNA Drug Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World mRNA Drug Consumption (2021-2032) & (K Dose)
Figure 15. World mRNA Drug Consumption Market Share by Region (2021-2032)
Figure 16. United States mRNA Drug Consumption (2021-2032) & (K Dose)
Figure 17. China mRNA Drug Consumption (2021-2032) & (K Dose)
Figure 18. Europe mRNA Drug Consumption (2021-2032) & (K Dose)
Figure 19. Japan mRNA Drug Consumption (2021-2032) & (K Dose)
Figure 20. South Korea mRNA Drug Consumption (2021-2032) & (K Dose)
Figure 21. ASEAN mRNA Drug Consumption (2021-2032) & (K Dose)
Figure 22. India mRNA Drug Consumption (2021-2032) & (K Dose)
Figure 23. Producer Shipments of mRNA Drug by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for mRNA Drug Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for mRNA Drug Markets in 2025
Figure 26. United States VS China: mRNA Drug Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: mRNA Drug Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: mRNA Drug Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers mRNA Drug Production Market Share 2025
Figure 30. China Based Manufacturers mRNA Drug Production Market Share 2025
Figure 31. Rest of World Based Manufacturers mRNA Drug Production Market Share 2025
Figure 32. World mRNA Drug Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World mRNA Drug Production Value Market Share by Type in 2025
Figure 34. Prophylactic Vaccine (Infectious Disease)
Figure 35. Therapeutic Vaccine (Cancer)
Figure 36. World mRNA Drug Production Market Share by Type (2021-2032)
Figure 37. World mRNA Drug Production Value Market Share by Type (2021-2032)
Figure 38. World mRNA Drug Average Price by Type (2021-2032) & (US$/Dose)
Figure 39. World mRNA Drug Production Value by Target Cell, (USD Million), 2021 & 2025 & 2032
Figure 40. World mRNA Drug Production Value Market Share by Target Cell in 2025
Figure 41. Intramuscular (Dendritic Cell) mRNA
Figure 42. Intravenous (Liver-targeted) mRNA
Figure 43. Intradermal (Skin APC) mRNA
Figure 44. Inhalation (Lung epithelial) mRNA
Figure 45. World mRNA Drug Production Market Share by Target Cell (2021-2032)
Figure 46. World mRNA Drug Production Value Market Share by Target Cell (2021-2032)
Figure 47. World mRNA Drug Average Price by Target Cell (2021-2032) & (US$/Dose)
Figure 48. World mRNA Drug Production Value by Manufacturing Scale, (USD Million), 2021 & 2025 & 2032
Figure 49. World mRNA Drug Production Value Market Share by Manufacturing Scale in 2025
Figure 50. Lab-scale (Preclinical, <1g)
Figure 51. Pilot-scale (Phase I/II, 1-100g)
Figure 52. Commercial-scale (Phase III/Market, >100g)
Figure 53. World mRNA Drug Production Market Share by Manufacturing Scale (2021-2032)
Figure 54. World mRNA Drug Production Value Market Share by Manufacturing Scale (2021-2032)
Figure 55. World mRNA Drug Average Price by Manufacturing Scale (2021-2032) & (US$/Dose)
Figure 56. World mRNA Drug Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 57. World mRNA Drug Production Value Market Share by Application in 2025
Figure 58. Pharmaceutical Companies
Figure 59. Medical Institutions
Figure 60. Others
Figure 61. World mRNA Drug Production Market Share by Application (2021-2032)
Figure 62. World mRNA Drug Production Value Market Share by Application (2021-2032)
Figure 63. World mRNA Drug Average Price by Application (2021-2032) & (US$/Dose)
Figure 64. mRNA Drug Industry Chain
Figure 65. mRNA Drug Procurement Model
Figure 66. mRNA Drug Sales Model
Figure 67. mRNA Drug Sales Channels, Direct Sales, and Distribution
Figure 68. Methodology
Figure 69. Research Process and Data Source
Figure 1. mRNA Drug Picture
Figure 2. World mRNA Drug Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World mRNA Drug Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World mRNA Drug Production (2021-2032) & (K Dose)
Figure 5. World mRNA Drug Average Price (2021-2032) & (US$/Dose)
Figure 6. World mRNA Drug Production Value Market Share by Region (2021-2032)
Figure 7. World mRNA Drug Production Market Share by Region (2021-2032)
Figure 8. North America mRNA Drug Production (2021-2032) & (K Dose)
Figure 9. Europe mRNA Drug Production (2021-2032) & (K Dose)
Figure 10. China mRNA Drug Production (2021-2032) & (K Dose)
Figure 11. Japan mRNA Drug Production (2021-2032) & (K Dose)
Figure 12. mRNA Drug Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World mRNA Drug Consumption (2021-2032) & (K Dose)
Figure 15. World mRNA Drug Consumption Market Share by Region (2021-2032)
Figure 16. United States mRNA Drug Consumption (2021-2032) & (K Dose)
Figure 17. China mRNA Drug Consumption (2021-2032) & (K Dose)
Figure 18. Europe mRNA Drug Consumption (2021-2032) & (K Dose)
Figure 19. Japan mRNA Drug Consumption (2021-2032) & (K Dose)
Figure 20. South Korea mRNA Drug Consumption (2021-2032) & (K Dose)
Figure 21. ASEAN mRNA Drug Consumption (2021-2032) & (K Dose)
Figure 22. India mRNA Drug Consumption (2021-2032) & (K Dose)
Figure 23. Producer Shipments of mRNA Drug by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for mRNA Drug Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for mRNA Drug Markets in 2025
Figure 26. United States VS China: mRNA Drug Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: mRNA Drug Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: mRNA Drug Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers mRNA Drug Production Market Share 2025
Figure 30. China Based Manufacturers mRNA Drug Production Market Share 2025
Figure 31. Rest of World Based Manufacturers mRNA Drug Production Market Share 2025
Figure 32. World mRNA Drug Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World mRNA Drug Production Value Market Share by Type in 2025
Figure 34. Prophylactic Vaccine (Infectious Disease)
Figure 35. Therapeutic Vaccine (Cancer)
Figure 36. World mRNA Drug Production Market Share by Type (2021-2032)
Figure 37. World mRNA Drug Production Value Market Share by Type (2021-2032)
Figure 38. World mRNA Drug Average Price by Type (2021-2032) & (US$/Dose)
Figure 39. World mRNA Drug Production Value by Target Cell, (USD Million), 2021 & 2025 & 2032
Figure 40. World mRNA Drug Production Value Market Share by Target Cell in 2025
Figure 41. Intramuscular (Dendritic Cell) mRNA
Figure 42. Intravenous (Liver-targeted) mRNA
Figure 43. Intradermal (Skin APC) mRNA
Figure 44. Inhalation (Lung epithelial) mRNA
Figure 45. World mRNA Drug Production Market Share by Target Cell (2021-2032)
Figure 46. World mRNA Drug Production Value Market Share by Target Cell (2021-2032)
Figure 47. World mRNA Drug Average Price by Target Cell (2021-2032) & (US$/Dose)
Figure 48. World mRNA Drug Production Value by Manufacturing Scale, (USD Million), 2021 & 2025 & 2032
Figure 49. World mRNA Drug Production Value Market Share by Manufacturing Scale in 2025
Figure 50. Lab-scale (Preclinical, <1g)
Figure 51. Pilot-scale (Phase I/II, 1-100g)
Figure 52. Commercial-scale (Phase III/Market, >100g)
Figure 53. World mRNA Drug Production Market Share by Manufacturing Scale (2021-2032)
Figure 54. World mRNA Drug Production Value Market Share by Manufacturing Scale (2021-2032)
Figure 55. World mRNA Drug Average Price by Manufacturing Scale (2021-2032) & (US$/Dose)
Figure 56. World mRNA Drug Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 57. World mRNA Drug Production Value Market Share by Application in 2025
Figure 58. Pharmaceutical Companies
Figure 59. Medical Institutions
Figure 60. Others
Figure 61. World mRNA Drug Production Market Share by Application (2021-2032)
Figure 62. World mRNA Drug Production Value Market Share by Application (2021-2032)
Figure 63. World mRNA Drug Average Price by Application (2021-2032) & (US$/Dose)
Figure 64. mRNA Drug Industry Chain
Figure 65. mRNA Drug Procurement Model
Figure 66. mRNA Drug Sales Model
Figure 67. mRNA Drug Sales Channels, Direct Sales, and Distribution
Figure 68. Methodology
Figure 69. Research Process and Data Source
